Abstract:
Bioactive sphingolipids such as ceramide, ceramide 1-phosphate, dihydroceramide, sphingosine, and sphingosine 1-phosphate have key roles in cell proliferation, differentiation, senescence, apoptosis, migration, carcinogenesis, inflammation, and angiogenesis. There has been much progress made in understanding the complex pathways of sphingolipid metabolism and identifying the enzymes involved in sphingolipid production. This chapter reviews the structure, metabolism and functions of these bioactive sphingolipids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- alk-SMase:
-
alkaline sphingomyelinase
- aSMase:
-
acid sphingomyelinase
- C1P:
-
ceramide 1-phoshpate
- CDase:
-
ceramidase
- Cer:
-
ceramide
- CERK:
-
ceramide kinase
- CerS:
-
(dihydro)ceramide synthases
- DAG:
-
diacylglycerol
- DEGS-1:
-
dihydroceramide desaturase
- dhCer:
-
dihydroceramide
- ER:
-
endoplasmic reticulum
- GalCer:
-
galactosylceramide
- GCS:
-
glucosylceramide synthase
- GluCer glucosylceramide; GSLs; glycosphingolipids; haCER:
-
human alkaline ceramidase
- haPHC:
-
human alkaline phytoceramidase
- MAMs:
-
mitochondria-associated membranes
- nSMase:
-
neutral sphingomyelinase
- PKC:
-
protein kinase C
- Rb:
-
retinoblastoma protein
- S1P:
-
sphingosine 1-phosphate
- SK:
-
sphingosine kinases
- SM:
-
sphingomyelin
- SMases:
-
sphingomyelinases
- Sph:
-
sphingosine
References
Ahn EH, Schroeder JJ. 2002. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp Biol Med (Maywood) 227: 345–353.
Bernardo K, Hurwitz R, Zenk T, Desnick RJ, Ferlinz K, et al. 1995. Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem 270: 11098–11102.
Bielawska A, Crane HM, Liotta D, Obeid LM, Hannun YA. 1993. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J Biol Chem 268: 26226–26232.
Biswal SS, Datta K, Acquaah-Mensah GK, Kehrer JP. 2000. Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells. Toxicology 154: 45–53.
Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, et al. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82: 405–414.
Chalfant CE, Rathman K, Pinkerman RL, Wood RE, Obeid LM, et al. 2002. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 277: 12587–12595.
Chalfant CE, Spiegel S. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling. J Cell Sci 118: 4605–4612.
Chang HC, Tsai LH, Chuang LY, Hung WC. 2001. Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J Cell Physiol 188: 188–193.
Clarke CJ, Hannun YA. 2006. Neutral sphingomyelinases and nSMase2: Bridging the gaps. Biochim Biophys Acta 1758: 1893–1901.
Conway A, Pyne NJ, Pyne S. 2000. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells. Cell Signal 12: 737–743.
Cuvillier O, Edsall L, Spiegel S. 2000. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 275: 15691–15700.
Cuvillier O, Nava VE, Murthy SK, Edsall LC, Levade T, et al. 2001. Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ 8: 162–171.
Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. 1993. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268: 15523–15530.
Duan RD, Cheng Y, Hansen G, Hertervig E, Liu JJ, et al. 2003. Purification, localization, and expression of human intestinal alkaline sphingomyelinase. J Lipid Res 44: 1241–1250.
El Bawab S, Birbes H, Roddy P, Szulc ZM, Bielawska A, et al. 2001. Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J Biol Chem 276: 16758–16766.
El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, et al. 2000. Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 275: 21508–21513.
Futerman AH, Hannun YA. 2004. The complex life of simple sphingolipids. EMBO Rep 5: 777–782.
Futerman AH, Riezman H. 2005. The ins and outs of sphingolipid synthesis. Trends Cell Biol 15: 312–318.
Gatt S. 1963. Enzymic Hydrolysis and Synthesis of Ceramides. J Biol Chem 238: 3131–3133.
Goldkorn T, Balaban N, Shannon M, Chea V, Matsukuma K, et al. 1998. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci 111 (Pt 21): 3209–3220.
Gomez del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M. 2002. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 363: 183–188.
Gomez-Munoz A. 2004. Ceramide-1-phosphate: A novel regulator of cell activation. FEBS Lett 562: 5–10.
Gomez-Munoz A, Duffy PA, Martin A, O’Brien L, Byun HS, et al. 1995. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: Antagonism by cell-permeable ceramides. Mol Pharmacol 47: 833–839.
Gomez-Munoz A, Kong JY, Salh B, Steinbrecher UP. 2004. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45: 99–105.
Hailemariam TK, Huan C, Liu J, Li Z, Roman C, et al. 2008. Sphingomyelin Synthase 2 Deficiency Attenuates NF{kappa}B Activation. Arterioscler Thromb Vasc Biol. 28: 1519-1526.
Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, et al. 1994. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525–535.
Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, et al. 2003. Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta. J Biol Chem 278: 41557–41565.
Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, et al. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426: 803–809.
Hannun YA, Loomis CR, Merrill AH, Jr., Bell RM. 1986. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261: 12604–12609.
Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139–150.
Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, et al. 1999. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. Embo J 18: 5252–5263.
Hinkovska-Galcheva V, Boxer LA, Kindzelskii A, Hiraoka M, Abe A, et al. 2005. Ceramide 1-phosphate, a mediator of phagocytosis. J Biol Chem 280: 26612–26621.
Hofmann K, Tomiuk S, Wolff G, Stoffel W. 2000. Cloning and characterization of the mammalian brain-specific, Mg2+ -dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 97: 5895–5900.
Hung WC, Chang HC, Chuang LY. 1999. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem J 338(Pt 1): 161–166.
Hwang YH, Tani M, Nakagawa T, Okino N, Ito M. 2005. Subcellular localization of human neutral ceramidase expressed in HEK293 cells. Biochem Biophys Res Commun 331: 37–42.
Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, et al. 2003. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278: 46832–46839.
Ikeda M, Kihara A, Igarashi Y. 2004. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun 325: 338–343.
Jarvis WD, Fornari FA, Jr., Auer KL, Freemerman AJ, Szabo E, et al. 1997. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 52: 935–947.
Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. 2004. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA 101: 17825–17830.
Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM. 2002. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277: 35257–35262.
Kim MY, Linardic C, Obeid L, Hannun Y. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266: 484–489.
Kitatani K, Idkowiak-Baldys J, Hannun YA. 2008. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20: 1010–1018.
Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, et al. 1998. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273: 23722–23728.
Kraveka JM, Li L, Szulc ZM, Bielawski J, Ogretmen B, et al. 2007. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem 282: 16718–16728.
Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, Kronke M. 2006. Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein. J Biol Chem 281: 13784–13793.
Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, et al. 2004. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 64: 3593–3598.
Lin T, Genestier L, Pinkoski MJ, Castro A, Nicholas S, et al. 2000. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem 275: 8657–8663.
Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, et al. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273: 11313–11320.
Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, et al. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275: 19513–19520.
Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, et al. 1994. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem 269: 19200–19202.
Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, et al. 2002. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277: 41128–41139.
Luberto C, Yoo DS, Suidan HS, Bartoli GM, Hannun YA. 2000. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem 275: 14760–14766.
Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH, et al. 2001. Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276: 26577–26588.
Marchesini N, Hannun YA. 2004. Acid and neutral sphingomyelinases: Roles and mechanisms of regulation. Biochem Cell Biol 82: 27–44.
Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L. 2000. Human sphingosine kinase: Molecular cloning, functional characterization and tissue distribution. Gene 251: 19–26.
Merrill AH, Jr. 2002. De novo sphingolipid biosynthesis: A necessary, but dangerous, pathway. J Biol Chem 277: 25843–25846.
Michel C, van Echten-Deckert G, Rother J, Sandhoff K, Wang E, et al. 1997. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 272: 22432–22437.
Mitsutake S, Kim TJ, Inagaki Y, Kato M, Yamashita T, et al. 2004. Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 279: 17570–17577.
Ogretmen B. 2006. Sphingolipids in cancer: Regulation of pathogenesis and therapy. FEBS Lett 580: 5467–5476.
Ogretmen B, Hannun YA. 2004. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604–616.
Okino N, He X, Gatt S, Sandhoff K, Ito M, et al. 2003. The reverse activity of human acid ceramidase. J Biol Chem 278: 29948–29953.
Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, et al. 2000. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275: 9078–9084.
Pettus BJ, Bielawska A, Subramanian P, Wijesinghe DS, Maceyka M, et al. 2004. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem 279: 11320–11326.
Pettus BJ, Bielawski J, Porcelli AM, Reames DL, Johnson KR, et al. 2003. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. Faseb J 17: 1411–1421.
Pewzner-Jung Y, Ben-Dor S, Futerman AH. 2006. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem 281: 25001–25005.
Pitson SM, D’Andrea RJ, Vandeleur L, Moretti PA, Xia P, et al. 2000. Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem J 350(Pt 2): 429–441.
Rosenfeldt HM, Hobson JP, Maceyka M, Olivera A, Nava VE, et al. 2001. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. Faseb J 15: 2649–2659.
Sawai H, Domae N, Nagan N, Hannun YA. 1999. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem 274: 38131–38139.
Schneider PB, Kennedy EP. 1967. Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8: 202–209.
Schulz A, Mousallem T, Venkataramani M, Persaud-Sawin DA, Zucker A, et al. 2006. The CLN9 protein, a regulator of dihydroceramide synthase. J Biol Chem 281: 2784–2794.
Schwandner R, Wiegmann K, Bernardo K, Kreder D, Kronke M. 1998. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem 273: 5916–5922.
Spiegel S, Milstien S. 2003. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397–407.
Stiban J, Fistere D, Colombini M. 2006. Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis 11: 773–780.
Strum JC, Small GW, Pauig SB, Daniel LW. 1994. 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269: 15493–15497.
Sugiki H, Hozumi Y, Maeshima H, Katagata Y, Mitsuhashi Y, et al. 2000. C2-ceramide induces apoptosis in a human squamous cell carcinoma cell line. Br J Dermatol 143: 1154–1163.
Sugiura M, Kono K, Liu H, Shimizugawa T, Minekura H, et al. 2002. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem 277: 23294–23300.
Sun W, Xu R, Hu W, Jin J, Crellin HA, et al. 2008. Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J Invest Dermatol 128: 389–397.
Suzuki A, Iwasaki M, Kato M, Wagai N. 1997. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp Cell Res 233: 41–47.
Taha TA, Mullen TD, Obeid LM. 2006. A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 1758: 2027–2036.
Tettamanti G. 2004. Ganglioside/glycosphingolipid turnover: New concepts. Glycoconj J 20: 301–317.
Tomiuk S, Zumbansen M, Stoffel W. 2000. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 275: 5710–5717.
Triola G, Fabrias G, Dragusin M, Niederhausen L, Broere R, et al. 2004. Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]o ctanamide (GT11) in primary cultured cerebellar neurons. Mol Pharmacol 66: 1671–1678.
Villani M, Subathra M, Im YB, Choi Y, Signorelli P, et al. 2008. Sphingomyelin synthases regulate production of diacylglycerol at the golgi. Biochem J 414: 31-41.
Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM, Hannun YA. 1994. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 269: 19605–19609.
Wymann MP, Schneiter R. 2008. Lipid signalling in disease. Nat Rev Mol Cell Biol 9: 162–176.
Xu R, Jin J, Hu W, Sun W, Bielawski J, et al. 2006. Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. Faseb J 20: 1813–1825.
Yamaguchi S, Suzuki K. 1977. Purification and characterization of sphingomyelinase from human brain. J Biol Chem 252: 3805–3813.
Zeidan YH, Hannun YA. 2007. Translational aspects of sphingolipid metabolism. Trends Mol Med 13: 327–336.
Zhang Y, Mattjus P, Schmid PC, Dong Z, Zhong S, et al. 2001. Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J Biol Chem 276: 11775–11782.
Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, et al. 2006. Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758: 1864–1884.
Zhou J, Saba JD. 1998. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem Biophys Res Commun 242: 502–507.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this entry
Cite this entry
Kraveka, J.M., Hannun, Y.A. (2009). Bioactive Sphingolipids: An Overview on Ceramide, Ceramide 1-Phosphate Dihydroceramide, Sphingosine, Sphingosine 1-Phosphate. In: Lajtha, A., Tettamanti, G., Goracci, G. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30378-9_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-30378-9_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30345-1
Online ISBN: 978-0-387-30378-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences